606O Initial results from a first-in-human study of the B7-H4-directed antibody-drug conjugate (ADC) AZD8205 (puxitatug samrotecan) in patients with advanced/metastatic solid tumors

Authors:
  • FMF. Meric-Bernstam
    F. Meric-Bernstam
  • YNY. Naito
    Y. Naito
  • SGS. Gaillard
    S. Gaillard
  • TST. Shimoi
    T. Shimoi
  • VCV. Chung
    V. Chung
  • ADA.A. Davis
    A.A. Davis
  • TPT. Proia
    T. Proia
  • AAA. Ayyoub
    A. Ayyoub
  • MKM. Kulkarni
    M. Kulkarni
  • SUS. Upadhyay
    S. Upadhyay
  • NMN. Miller
    N. Miller
  • NLN. Luheshi
    N. Luheshi

Abstract
No abstract available